19 June 2013
Keywords: gsk, ph, iii, entereg, trial, completes, enrollment
Article | 24 April 2006
UK drug major GlaxoSmithKline has completed enrollment of a Phase III clinical program to evaluate the efficacy and safety of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 April 2006
18 June 2013
© 2013 thepharmaletter.com